Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-dose adjuvanted IPV booster in adolescents
NCT02280447Phase 2Completed
- Sponsor
- Statens Serum Institut
- Start
- Nov 2014
- Primary completion
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Picovax in poliomyelitis, sponsored by Statens Serum Institut. Started Nov 2014; status: completed.
02
Drugs
Picovax
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT02280447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280447.